TrialEBioMedicine2026

Tumour cell density quantified by artificial intelligence is associated with differential benefit from irinotecan-based chemo-radiotherapy in locally advanced rectal cancer: a post-hoc study of the phase 3 ARISTOTLE trial.

Zhuoyan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.